Muireann Bolger

Key details

Muireann Bolger is deputy editor of World Intellectual Property Review and Life Sciences Intellectual Property Review in London, where she covers trademarks, brands, as well as wider developments across the intellectual property sector.

She regularly attends and covers major IP conferences around the world, reporting on the latest legal, commercial and policy developments and interviewing leading figures from across the sector. She has also co-authored industry reports with leading IP organisations, including the International Trademark Association (INTA).

She is the editor of the website’s Community & Inclusion channel and the annual Influential Women in IP list, which celebrates the achievements and contributions of leading women across the IP sector.

Originally from Ireland, Muireann has nearly two decades of experience reporting on brand developments, strategy, and wider business issues.

In her current role, she writes and edits news and analysis for an international audience of IP professionals, while also championing inclusion within the profession.

Reset all filters
Article Type
Channels & Sectors
Geography
Company
Refine search
Total results: 415

Articles by Muireann Bolger

Moderna in dispute with US govt over COVID-19 vaccine inventors
Americas
Moderna is facing accusations from the US National Institute of Health that it failed to give due recognition to three scientists as inventors on its COVID-19 vaccine application.   11 November 2021
China accepts cluster of complaints under new patent linkage law
Asia
The China National Intellectual Property Administration has accepted its first set of drug patent linkage complaints since the introduction of a new patent law in June 2021.   9 November 2021
Zetia buyers secure backing for ‘market narrowing’ in MSD antitrust case
Americas
Wholesale buyers of the cholesterol treatment Zetia have won the backing of a US judge for their market definition in an antitrust suit against MSD and Glenmark.   4 November 2021
Americas
Medical device company Nevro has been hit with a $20m damages verdict after a US jury found that it had infringed two patents owned by Boston Scientific.   2 November 2021
Americas
Azurity Pharmaceuticals has sued Florida-based generic manufacturer CoreRx for infringing a pair of patents covering a hypertension drug for children.   28 October 2021
Americas
St Jude Medical will be able to claw back some of the attorney fees and expenses it incurred defending a suit filed by Niazi Licensing Corporation in a dispute over a patent covering a heart catheter.   26 October 2021
Americas
Law firm Kilpatrick Townsend & Stockton has announced the addition of Stuart Pollack to the firm’s New York office as a partner on the patent litigation team.   21 October 2021
Americas
Apple has secured the backing of a major pharmaceutical industry trade association, as it seeks to persuade the US Court of Appeals for the Federal Circuit to revisit a case centring on a pair of health sensor patents.   19 October 2021
Americas
Medical device company, Globus Medical, has filed a lawsuit against competitor Life Spine, alleging infringement of seven different patents related to spinal tech implant technology.   14 October 2021
Americas
The unpredictable nature of the US legal landscape has arguably kept IP practitioners on tenterhooks over the past decade.   7 October 2021

Not finding what you're looking for, please try resetting your applied search and filters,
or try the
full site search.